Laura Pioppo

Jun 22, 2023 | bpspubs.onlinelibrary.wiley.com | Rosa Gonzalez-Quevedo |Juan Garcia Burgos |Peter Arlett |Laura Pioppo

Academics, clinical researchers, drug developers and other key stakeholders such as patient advocates are being encouraged to take part in a public consultation1 recently launched by the European Medicines Agency (EMA) that will inform re-shaping of the EU transparency rules for clinical trials.